RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
157 hedge funds and large institutions have $1.4B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 47
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
157
Holding in Top 10
5
Calls
$12.2M
Puts
$9.37M
Top Buyers
| 1 | +$36.5M | |
| 2 | +$30.2M | |
| 3 | +$14.2M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$11.5M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$9.91M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$11.9M | |
| 3 | -$10.8M | |
| 4 |
BlackRock
New York
|
-$8.66M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.33M |